Merck KGaA, Darmstadt, Germany and Broad Institute Announce CRISPR License Framework to Encourage Innovation
18 JUL 2019 | DARMSTADT, GERMANY New framework simplifies and accelerates access to CRISPR intellectual property for research Merck KGaA, Darmstadt, Germany, a leading science and technology company, and the Broad Institute of MIT and Harvard today announced an agreement between Broad Institute and the Life Science business of Merck KGaA, Darmstadt, Germany to offer non-exclusive licenses... Read more